×

PTGFRN cDNA ORF clone, Homo sapiens (human)

Gene Symbol PTGFRN
Entrez Gene ID 5738
Full Name prostaglandin F2 receptor inhibitor
Synonyms CD315, CD9P-1, EWI-F, FPRP, SMAP-6
Gene Type protein-coding
Organism Homo sapiens (human)
Genome

1

1p13.1

Summary lac of sum
Disorder MIM:

601204


mRNA and Protein(s)

mRNA Protein Name
NM_020440 NP_065173 prostaglandin F2 receptor negative regulator precursor


Homo sapiens (human) PTGFRN NP_065173.2
Pan troglodytes (chimpanzee) PTGFRN XP_003308360.1
Macaca mulatta (Rhesus monkey) PTGFRN XP_001103382.2
Canis lupus familiaris (dog) PTGFRN XP_005630930.1
Bos taurus (cattle) PTGFRN XP_002686168.2
Mus musculus (house mouse) Ptgfrn NP_035327.2
Rattus norvegicus (Norway rat) Ptgfrn NP_062116.1
Gallus gallus (chicken) PTGFRN XP_416660.4
Danio rerio (zebrafish) si:ch211-132g1.7 XP_005168370.1
Xenopus (Silurana) tropicalis (western clawed frog) LOC100493252 XP_002943881.2


GeneRIFs: Gene References Into Functions What's a GeneRIF?

The following PTGFRN gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the PTGFRN cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

***CloneID RefSeq Accession Definition **Vector *Turnaround time Price Select
OHu60007 NM_020440 Homo sapiens prostaglandin F2 receptor inhibitor (PTGFRN), mRNA. pcDNA3.1+/C-(K)DYK or customized vector 12-14 $265.30
$379.00
Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone 30% OFF
2-4 Clone 40% OFF
5 or more Clone 50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.


CloneID OHu60007
Clone ID Related Accession (Same CDS sequence) NM_020440
Accession Version NM_020440.3 Documents for ORF clone product in dufault vector
Sequence Information ORF Nucleotide Sequence (Length: 2640bp)
Protein sequence
SNP
Vector pcDNA3.1+/C-(K)DYK or customized vector User Manual
Clone information Clone Map MSDS
Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
ORF Insert Method CloneEZ® Seamless cloning technology
Structure linear
Update Date 15-MAR-2015
Organism Homo sapiens (human)
Product prostaglandin F2 receptor negative regulator precursor
Comment VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from DA572787.1, AB037857.1, AK074637.1 and AA045111.1. On Dec 11, 2014 this sequence version replaced gi:41152505. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: BC152454.1, AB037857.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA1966682, SAMEA1968189 [ECO:0000348] ##Evidence-Data-END##

1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521
2581
ATGGGGCGCC TGGCCTCGAG GCCGCTGCTG CTGGCGCTCC TGTCGTTGGC TCTTTGCCGA 
GGGCGTGTGG TGAGAGTCCC CACAGCGACC CTGGTTCGAG TGGTGGGCAC TGAGCTGGTC
ATCCCCTGCA ACGTCAGTGA CTATGATGGC CCCAGCGAGC AAAACTTTGA CTGGAGCTTC
TCATCTTTGG GGAGCAGCTT TGTGGAGCTT GCAAGCACCT GGGAGGTGGG GTTCCCAGCC
CAGCTGTACC AGGAGCGGCT GCAGAGGGGC GAGATCCTGT TAAGGCGGAC TGCCAACGAC
GCCGTGGAGC TCCACATAAA GAACGTCCAG CCTTCAGACC AAGGCCACTA CAAATGTTCA
ACCCCCAGCA CAGATGCCAC TGTCCAGGGA AACTATGAGG ACACAGTGCA GGTTAAAGTG
CTGGCCGACT CCCTGCACGT GGGCCCCAGC GCGCGGCCCC CGCCGAGCCT GAGCCTGCGG
GAGGGGGAGC CCTTCGAGCT GCGCTGCACC GCCGCCTCCG CCTCGCCGCT GCACACGCAC
CTGGCGCTGC TGTGGGAGGT GCACCGCGGC CCGGCCAGGC GGAGCGTCCT CGCCCTGACC
CACGAGGGCA GGTTCCACCC GGGCCTGGGG TACGAGCAGC GCTACCACAG TGGGGACGTG
CGCCTCGACA CCGTGGGCAG CGACGCCTAC CGCCTCTCAG TGTCCCGGGC TCTGTCTGCC
GACCAGGGCT CCTACAGGTG TATCGTCAGC GAGTGGATCG CCGAGCAGGG CAACTGGCAG
GAAATCCAAG AAAAGGCCGT GGAAGTTGCC ACCGTGGTGA TCCAGCCATC AGTTCTGCGA
GCAGCTGTGC CCAAGAATGT GTCTGTGGCT GAAGGAAAGG AACTGGACCT GACCTGTAAC
ATCACAACAG ACCGAGCCGA TGACGTCCGG CCCGAGGTGA CGTGGTCCTT CAGCAGGATG
CCTGACAGCA CCCTACCTGG CTCCCGCGTG TTGGCGCGGC TTGACCGTGA TTCCCTGGTG
CACAGCTCGC CTCATGTTGC TTTGAGTCAT GTGGATGCAC GCTCCTACCA TTTACTGGTT
CGGGATGTTA GCAAAGAAAA CTCTGGCTAC TATTACTGCC ACGTGTCCCT GTGGGCACCC
GGACACAACA GGAGCTGGCA CAAAGTGGCA GAGGCCGTGT CTTCCCCAGC TGGTGTGGGT
GTGACCTGGC TAGAACCAGA CTACCAGGTG TACCTGAATG CTTCCAAGGT CCCCGGGTTT
GCGGATGACC CCACAGAGCT GGCATGCCGG GTGGTGGACA CGAAGAGTGG GGAGGCGAAT
GTCCGATTCA CGGTTTCGTG GTACTACAGG ATGAACCGGC GCAGCGACAA TGTGGTGACC
AGCGAGCTGC TTGCAGTCAT GGACGGGGAC TGGACGCTAA AATATGGAGA GAGGAGCAAG
CAGCGGGCCC AGGATGGAGA CTTTATTTTT TCTAAGGAAC ATACAGACAC GTTCAATTTC
CGGATCCAAA GGACTACAGA GGAAGACAGA GGCAATTATT ACTGTGTTGT GTCTGCCTGG
ACCAAACAGC GGAACAACAG CTGGGTGAAA AGCAAGGATG TCTTCTCCAA GCCTGTTAAC
ATATTTTGGG CATTAGAAGA TTCCGTGCTT GTGGTGAAGG CGAGGCAGCC AAAGCCTTTC
TTTGCTGCCG GAAATACATT TGAGATGACT TGCAAAGTAT CTTCCAAGAA TATTAAGTCG
CCACGCTACT CTGTTCTCAT CATGGCTGAG AAGCCTGTCG GCGACCTCTC CAGTCCCAAT
GAAACGAAGT ACATCATCTC TCTGGACCAG GATTCTGTGG TGAAGCTGGA GAATTGGACA
GATGCATCAC GGGTGGATGG CGTTGTTTTA GAAAAAGTGC AGGAGGATGA GTTCCGCTAT
CGAATGTACC AGACTCAGGT CTCAGACGCA GGGCTGTACC GCTGCATGGT GACAGCCTGG
TCTCCTGTCA GGGGCAGCCT TTGGCGAGAA GCAGCAACCA GTCTCTCCAA TCCTATTGAG
ATAGACTTCC AAACCTCAGG TCCTATATTT AATGCTTCTG TGCATTCAGA CACACCATCA
GTAATTCGGG GAGATCTGAT CAAATTGTTC TGTATCATCA CTGTCGAGGG AGCAGCACTG
GATCCAGATG ACATGGCCTT TGATGTGTCC TGGTTTGCGG TGCACTCTTT TGGCCTGGAC
AAGGCTCCTG TGCTCCTGTC TTCCCTGGAT CGGAAGGGCA TCGTGACCAC CTCCCGGAGG
GACTGGAAGA GCGACCTCAG CCTGGAGCGC GTGAGTGTGC TGGAATTCTT GCTGCAAGTG
CATGGCTCCG AGGACCAGGA CTTTGGCAAC TACTACTGTT CCGTGACTCC ATGGGTGAAG
TCACCAACAG GTTCCTGGCA GAAGGAGGCA GAGATCCACT CCAAGCCCGT TTTTATAACT
GTGAAGATGG ATGTGCTGAA CGCCTTCAAG TATCCCTTGC TGATCGGCGT CGGTCTGTCC
ACGGTCATCG GGCTCCTGTC CTGTCTCATC GGGTACTGCA GCTCCCACTG GTGTTGTAAG
AAGGAGGTTC AGGAGACACG GCGCGAGCGC CGCAGGCTCA TGTCGATGGA GATGGACTAG

The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

RefSeq NP_065173.2
CDS282..2921
Misc Feature(1)369..701(+)
Misc Feature(2)396..644(+)
Misc Feature(3)591..704(+)
Misc Feature(4)1092..1094(+)
Misc Feature(5)1128..>1394(+)
Misc Feature(6)1131..1409(+)
Misc Feature(7)1551..1562(+)
Misc Feature(8)2388..2396(+)
Misc Feature(9)2778..2840(+)
Exon (1)1..330
Gene:PTGFRN
Gene Synonym:
Exon (2)331..699
Gene:PTGFRN
Gene Synonym:
Exon (3)700..1113
Gene:PTGFRN
Gene Synonym:
Exon (4)1114..1494
Gene:PTGFRN
Gene Synonym:
Exon (5)1495..1920
Gene:PTGFRN
Gene Synonym:
Exon (6)1921..2340
Gene:PTGFRN
Gene Synonym:
Exon (7)2341..2448
Gene:PTGFRN
Gene Synonym:
Exon (8)2449..2754
Gene:PTGFRN
Gene Synonym:
Exon (9)2755..6312
Gene:PTGFRN
Gene Synonym:
Translation

Target ORF information:

RefSeq Version NM_020440
Organism Homo sapiens (human)
Definition Homo sapiens prostaglandin F2 receptor inhibitor (PTGFRN), mRNA.

Target ORF information:

Epitope DYKDDDDK
Bacterial selection AMPR
Mammalian selection NeoR
Vector pcDNA3.1+/C-(K)DYK
NM_020440

ORF Insert Sequence:

1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521
2581
ATGGGGCGCC TGGCCTCGAG GCCGCTGCTG CTGGCGCTCC TGTCGTTGGC TCTTTGCCGA 
GGGCGTGTGG TGAGAGTCCC CACAGCGACC CTGGTTCGAG TGGTGGGCAC TGAGCTGGTC
ATCCCCTGCA ACGTCAGTGA CTATGATGGC CCCAGCGAGC AAAACTTTGA CTGGAGCTTC
TCATCTTTGG GGAGCAGCTT TGTGGAGCTT GCAAGCACCT GGGAGGTGGG GTTCCCAGCC
CAGCTGTACC AGGAGCGGCT GCAGAGGGGC GAGATCCTGT TAAGGCGGAC TGCCAACGAC
GCCGTGGAGC TCCACATAAA GAACGTCCAG CCTTCAGACC AAGGCCACTA CAAATGTTCA
ACCCCCAGCA CAGATGCCAC TGTCCAGGGA AACTATGAGG ACACAGTGCA GGTTAAAGTG
CTGGCCGACT CCCTGCACGT GGGCCCCAGC GCGCGGCCCC CGCCGAGCCT GAGCCTGCGG
GAGGGGGAGC CCTTCGAGCT GCGCTGCACC GCCGCCTCCG CCTCGCCGCT GCACACGCAC
CTGGCGCTGC TGTGGGAGGT GCACCGCGGC CCGGCCAGGC GGAGCGTCCT CGCCCTGACC
CACGAGGGCA GGTTCCACCC GGGCCTGGGG TACGAGCAGC GCTACCACAG TGGGGACGTG
CGCCTCGACA CCGTGGGCAG CGACGCCTAC CGCCTCTCAG TGTCCCGGGC TCTGTCTGCC
GACCAGGGCT CCTACAGGTG TATCGTCAGC GAGTGGATCG CCGAGCAGGG CAACTGGCAG
GAAATCCAAG AAAAGGCCGT GGAAGTTGCC ACCGTGGTGA TCCAGCCATC AGTTCTGCGA
GCAGCTGTGC CCAAGAATGT GTCTGTGGCT GAAGGAAAGG AACTGGACCT GACCTGTAAC
ATCACAACAG ACCGAGCCGA TGACGTCCGG CCCGAGGTGA CGTGGTCCTT CAGCAGGATG
CCTGACAGCA CCCTACCTGG CTCCCGCGTG TTGGCGCGGC TTGACCGTGA TTCCCTGGTG
CACAGCTCGC CTCATGTTGC TTTGAGTCAT GTGGATGCAC GCTCCTACCA TTTACTGGTT
CGGGATGTTA GCAAAGAAAA CTCTGGCTAC TATTACTGCC ACGTGTCCCT GTGGGCACCC
GGACACAACA GGAGCTGGCA CAAAGTGGCA GAGGCCGTGT CTTCCCCAGC TGGTGTGGGT
GTGACCTGGC TAGAACCAGA CTACCAGGTG TACCTGAATG CTTCCAAGGT CCCCGGGTTT
GCGGATGACC CCACAGAGCT GGCATGCCGG GTGGTGGACA CGAAGAGTGG GGAGGCGAAT
GTCCGATTCA CGGTTTCGTG GTACTACAGG ATGAACCGGC GCAGCGACAA TGTGGTGACC
AGCGAGCTGC TTGCAGTCAT GGACGGGGAC TGGACGCTAA AATATGGAGA GAGGAGCAAG
CAGCGGGCCC AGGATGGAGA CTTTATTTTT TCTAAGGAAC ATACAGACAC GTTCAATTTC
CGGATCCAAA GGACTACAGA GGAAGACAGA GGCAATTATT ACTGTGTTGT GTCTGCCTGG
ACCAAACAGC GGAACAACAG CTGGGTGAAA AGCAAGGATG TCTTCTCCAA GCCTGTTAAC
ATATTTTGGG CATTAGAAGA TTCCGTGCTT GTGGTGAAGG CGAGGCAGCC AAAGCCTTTC
TTTGCTGCCG GAAATACATT TGAGATGACT TGCAAAGTAT CTTCCAAGAA TATTAAGTCG
CCACGCTACT CTGTTCTCAT CATGGCTGAG AAGCCTGTCG GCGACCTCTC CAGTCCCAAT
GAAACGAAGT ACATCATCTC TCTGGACCAG GATTCTGTGG TGAAGCTGGA GAATTGGACA
GATGCATCAC GGGTGGATGG CGTTGTTTTA GAAAAAGTGC AGGAGGATGA GTTCCGCTAT
CGAATGTACC AGACTCAGGT CTCAGACGCA GGGCTGTACC GCTGCATGGT GACAGCCTGG
TCTCCTGTCA GGGGCAGCCT TTGGCGAGAA GCAGCAACCA GTCTCTCCAA TCCTATTGAG
ATAGACTTCC AAACCTCAGG TCCTATATTT AATGCTTCTG TGCATTCAGA CACACCATCA
GTAATTCGGG GAGATCTGAT CAAATTGTTC TGTATCATCA CTGTCGAGGG AGCAGCACTG
GATCCAGATG ACATGGCCTT TGATGTGTCC TGGTTTGCGG TGCACTCTTT TGGCCTGGAC
AAGGCTCCTG TGCTCCTGTC TTCCCTGGAT CGGAAGGGCA TCGTGACCAC CTCCCGGAGG
GACTGGAAGA GCGACCTCAG CCTGGAGCGC GTGAGTGTGC TGGAATTCTT GCTGCAAGTG
CATGGCTCCG AGGACCAGGA CTTTGGCAAC TACTACTGTT CCGTGACTCC ATGGGTGAAG
TCACCAACAG GTTCCTGGCA GAAGGAGGCA GAGATCCACT CCAAGCCCGT TTTTATAACT
GTGAAGATGG ATGTGCTGAA CGCCTTCAAG TATCCCTTGC TGATCGGCGT CGGTCTGTCC
ACGGTCATCG GGCTCCTGTC CTGTCTCATC GGGTACTGCA GCTCCCACTG GTGTTGTAAG
AAGGAGGTTC AGGAGACACG GCGCGAGCGC CGCAGGCTCA TGTCGATGGA GATGGACTAG

The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

book

CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth
Br. J. Cancer 104 (3), 496-504 (2011)
Guilmain W, Colin S, Legrand E, Vannier JP, Steverlynck C, Bongaerts M, Vasse M and Al-Mahmood S.


book

Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer
Int. J. Radiat. Oncol. Biol. Phys. 78 (5), 1292-1300 (2010)
Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L and Rosenstein BS.


book

Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches
Biol. Psychiatry 67 (3), 263-269 (2010)
Ikeda M, Tomita Y, Mouri A, Koga M, Okochi T, Yoshimura R, Yamanouchi Y, Kinoshita Y, Hashimoto R, Williams HJ, Takeda M, Nakamura J, Nabeshima T, Owen MJ, O'Donovan MC, Honda H, Arinami T, Ozaki N and Iwata N.


book

In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface
J Proteomics 73 (1), 93-102 (2009)
Andre M, Chambrion C, Charrin S, Soave S, Chaker J, Boucheix C, Rubinstein E and Le Naour F.


book

Quantitative proteomics identifies a Dab2/integrin module regulating cell migration
J. Cell Biol. 186 (1), 99-111 (2009)
Teckchandani A, Toida N, Goodchild J, Henderson C, Watts J, Wollscheid B and Cooper JA.


book

The major CD9 and CD81 molecular partner. Identification and characterization of the complexes
J. Biol. Chem. 276 (17), 14329-14337 (2001)
Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C and Rubinstein E.


book

FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein
J. Biol. Chem. 276 (7), 4853-4862 (2001)
Stipp CS, Orlicky D and Hemler ME.


book

Synthesis and accumulation of a receptor regulatory protein associated with lipid droplet accumulation in 3T3-L1 cells
J. Lipid Res. 39 (6), 1152-1161 (1998)
Orlicky DJ, Lieber JG, Morin CL and Evans RM.


book

Human chromosome 1 localization of the gene for a prostaglandin F2alpha receptor negative regulatory protein
Hum. Genet. 97 (5), 655-658 (1996)
Orlicky DJ, Berry R and Sikela JM.


book

Negative regulatory activity of a prostaglandin F2 alpha receptor associated protein (FPRP)
Prostaglandins Leukot. Essent. Fatty Acids 54 (4), 247-259 (1996)
Orlicky DJ.


 
*
*
*
*